• Mergers Among Biotech Stocks Could Rise In 2019 firstwordpharma
    December 25, 2018
    According to analysts at RBC Capital Markets, Sarepta Therapeutics, Sage Therapeutics and Loxo Oncology are the most likely takeover targets among biotechnology firms in 2019, reported Investor's Business Daily. Sarepta is working on a gene therapy in a m
PharmaSources Customer Service